Abstract
A Canadian plan for pandemic influenza was completed by the National Advisory Committee on Immunization in 1988. Its development took several years and involved consultation with provincial public health and laboratory authorities, the licensing body, manufacturers of influenza vaccine and antiviral agents, and representatives in the USA and UK. Key decisions in creating the pandemic plan include: (1) aiming for federal-provincial consensus on use of vaccine and antiviral drugs, (2) a selective vaccination approach (high-risk persons plus essential workers), (3) bulk purchasing and distribution of vaccine through the public sector, (4) leaving antiviral drugs on the open market, (5) careful planning of the communications strategy, and (6) increasing inter-pandemic use of flu vaccine in target groups. The plan addresses recognition of a pandemic; activation of a Pandemic Influenza Committee whose membership and responsibilities are spelled out; the federal-provincial decision making process; influenza vaccine considerations; amantadine and other antiviral agents; estimates of target group size, vaccine uptake, manufacturing capabilities and time frames; and communication considerations. Since 1988, influenza vaccine use has increased considerably in Canada and experience has been gained with amantadine. Manufacturing capability within Canada for influenza vaccine has also been enhanced. It is now time to update the plan, especially the targets, and to make sure that everyone involved remains aware of the assigned roles.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
NACI. Statement on influenza vaccination for the 1993/94 season. Can Commun Dis Rep 1993; 19: 65–71.
Canadian Consensus Conference on Influenza. Can Commun Dis Rep 1993; 19: 136–146.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tamblyn, S.E. Pandemic planning in Canada. Eur J Epidemiol 10, 503–505 (1994). https://doi.org/10.1007/BF01719688
Issue Date:
DOI: https://doi.org/10.1007/BF01719688